# USAGE OF ARITIFICIAL INTELLIGENCE IN AIDING WITH COLONIC SESSILE SERRATED LESIONS DETECTION AND DIAGNOSIS (AI-SSL)

> **NCT07650344** · NA · RECRUITING · sponsor: **National Healthcare Group, Singapore** · enrollment: 628 (estimated)

## Conditions studied

- Sessile Serrated Lesion
- CADe

## Interventions

- **DEVICE:** usage of CADe system

## Key facts

- **NCT ID:** NCT07650344
- **Lead sponsor:** National Healthcare Group, Singapore
- **Sponsor class:** OTHER_GOV
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-05-21
- **Primary completion:** 2027-05
- **Final completion:** 2027-05-03
- **Target enrollment:** 628 (ESTIMATED)
- **Last updated:** 2026-06-16

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07650344

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07650344, "USAGE OF ARITIFICIAL INTELLIGENCE IN AIDING WITH COLONIC SESSILE SERRATED LESIONS DETECTION AND DIAGNOSIS (AI-SSL)". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07650344. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*